Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca

Clinical trial NCT04921904 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04921904
Sponsor: Baylor Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Esophageal Adenocarcinoma Metastatic Gastroesophageal Junction Adenocarcinoma

Start date: 2021-06-11
Primary completion: 2024-12-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.